These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 21269839

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
    Tacken PJ, de Vries IJ, Torensma R, Figdor CG.
    Nat Rev Immunol; 2007 Oct; 7(10):790-802. PubMed ID: 17853902
    [Abstract] [Full Text] [Related]

  • 3. Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro.
    Cruz LJ, Tacken PJ, Fokkink R, Joosten B, Stuart MC, Albericio F, Torensma R, Figdor CG.
    J Control Release; 2010 Jun 01; 144(2):118-26. PubMed ID: 20156497
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK, Stephani J, Schaefer M, Kalay H, García-Vallejo JJ, den Haan J, Saeland E, Sparwasser T, van Kooyk Y.
    Mol Immunol; 2009 Dec 01; 47(2-3):164-74. PubMed ID: 19818504
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 'Dressed for success' C-type lectin receptors for the delivery of glyco-vaccines to dendritic cells.
    Unger WW, van Kooyk Y.
    Curr Opin Immunol; 2011 Feb 01; 23(1):131-7. PubMed ID: 21169001
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma.
    Sun K, Wang L, Zhang Y.
    Cell Mol Immunol; 2006 Jun 01; 3(3):197-203. PubMed ID: 16893500
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fusion of CpG-ODN-stimulating dendritic cells with Lewis lung cancer cells can enhance anti-tumor immune responses.
    Du YC, Lin P, Zhang J, Lu YR, Ning QZ, Wang Q.
    Tissue Antigens; 2006 May 01; 67(5):368-76. PubMed ID: 16671943
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
    Kim JH, Kang TH, Noh KH, Bae HC, Kim SH, Yoo YD, Seong SY, Kim TW.
    Immunol Lett; 2009 Jan 29; 122(1):58-67. PubMed ID: 19135479
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Dendritic cells of mucosa and skin: "recruited for vaccination"].
    Le Borgne M, Dubois B, Kaiserlian D.
    Med Sci (Paris); 2007 Oct 29; 23(10):819-25. PubMed ID: 17937889
    [Abstract] [Full Text] [Related]

  • 18. The use of dendritic cells in cancer immunotherapy.
    Nencioni A, Grünebach F, Schmidt SM, Müller MR, Boy D, Patrone F, Ballestrero A, Brossart P.
    Crit Rev Oncol Hematol; 2008 Mar 29; 65(3):191-9. PubMed ID: 18055210
    [Abstract] [Full Text] [Related]

  • 19. Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine.
    den Brok MH, Sutmuller RP, Nierkens S, Bennink EJ, Toonen LW, Figdor CG, Ruers TJ, Adema GJ.
    Cancer Res; 2006 Jul 15; 66(14):7285-92. PubMed ID: 16849578
    [Abstract] [Full Text] [Related]

  • 20. Immunotherapy with dendritic cells for cancer.
    Ballestrero A, Boy D, Moran E, Cirmena G, Brossart P, Nencioni A.
    Adv Drug Deliv Rev; 2008 Jan 14; 60(2):173-83. PubMed ID: 17977615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.